Amicus Therapeutics Equity 2024

Amicus Therapeutics Aktienanalyse

What does Amicus Therapeutics do?

Amicus Therapeutics Inc. is a biopharmaceutical company specializing in the development of drugs for the treatment of rare diseases. The company was founded in 2002 and is headquartered in Cranbury, New Jersey. Amicus Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Amicus Therapeutics's Equity

Amicus Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Amicus Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Amicus Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Amicus Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Amicus Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Amicus Therapeutics stock

What is the equity of Amicus Therapeutics this year?

Amicus Therapeutics has equity of 160.17 M USD this year.

What was the equity of Amicus Therapeutics compared to the previous year?

The equity of Amicus Therapeutics has increased/decreased by 30.22% increased compared to the previous year.

What impact does a high equity have on investors of Amicus Therapeutics?

A high equity is advantageous for investors of Amicus Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Amicus Therapeutics?

A low equity can be a risk for investors of Amicus Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Amicus Therapeutics affect the company?

An increase in equity of Amicus Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Amicus Therapeutics affect the company?

A reduction in equity of Amicus Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Amicus Therapeutics?

Some factors that can affect the equity of Amicus Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Amicus Therapeutics so important for investors?

The equity of Amicus Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Amicus Therapeutics take to change the equity?

To change equity, Amicus Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Amicus Therapeutics pay?

Over the past 12 months, Amicus Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amicus Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Amicus Therapeutics?

The current dividend yield of Amicus Therapeutics is .

When does Amicus Therapeutics pay dividends?

Amicus Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amicus Therapeutics?

Amicus Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Amicus Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amicus Therapeutics located?

Amicus Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amicus Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amicus Therapeutics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Amicus Therapeutics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Amicus Therapeutics in the year 2023?

In the year 2023, Amicus Therapeutics distributed 0 USD as dividends.

In which currency does Amicus Therapeutics pay out the dividend?

The dividends of Amicus Therapeutics are distributed in USD.